"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc.
"Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."--Michael A. Greeley, Managing General Partner, IDG Ventures.
An in-depth examination of the growth and financing of the biotechnology industry worldwide
Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it's being applied, and where money and intellectual capital are flowing.
Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives Eos and other senior-level managers an understanding of Asia's pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.
Les mer
"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks.

Preface xi

Acknowledgments xvii

CHAPTER 1

Overview 1

CHAPTER 2

Pharmaceuticals 43

CHAPTER 3

Medicine and Agriculture 77

CHAPTER 4

Computing, Biomaterials, and the Military 105

CHAPTER 5

Infrastructure 142

CHAPTER 6

Financing 175

CHAPTER 7

Regional Analysis 217

CHAPTER 8

Outlook 295

Appendix 319

Glossary 329

Sources and Further Reading 337

Index 347

Les mer
"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping, insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."
—John P. Glaser
Vice President and Chief Information Officer
Partners Healthcare System, Inc.

"Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge."
—Michael A. Greeley
Managing General Partner
IDG Ventures

An in-depth examination of the growth and financing of the biotechnology industry worldwide

Biotech Industry: A Global, Economic, and Financing Overview provides a thorough look at the current state of the biotechnology industry, including where major research is being conducted, where it’s being applied, and where money and intellectual capital are flowing.

Written by a renowned business columnist and an entrepreneurial scientist in the biotech area, this unique book gives CEOs and other senior-level managers an understanding of Asia’s pivotal role in the worldwide success of biotechnology commercialization, as well as insight into the biotech market over the next decade.

Les mer
“The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential.”—John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc.

“Bergeron and Chan have done a marvelous job integrating many different perspectives to give the reader a coherent road map of the biotech industry for the next decade. This powerful book is anchored by numerous relevant examples that create a framework which any life sciences professional needs to understand. Of particular note is the compelling assessment of the IT industry and its impact on the life sciences as these industries converge.”—Michael A. Greeley, Managing General Partner, IDG Ventures.

Les mer
The biotechnology revolution is profoundly transforming medicine, agriculture, material science, the military, and even our identities. This global business phenomenon spans from front line users of the technology to thousands of local and multinational companies that provide everything from the high-tech reagents and raw biological materials to the stainless steel fermentation tanks and other equipment required to synthesize and transport biologicals.

Looking beyond the hype of get-rich-quick investment schemes, Biotech Industry: A Global, Economic, and Financing Overview provides CEOs and other upper-level managers with a comprehensive, critical analysis of the biotechnology business from a uniquely Pan-Asia perspective.

With a cutting-edge focus for forward-thinking business leaders, this reliable reference offers a clear vision of the global biotech market through 2010, including which regions and corporations are best positioned to dominate the market.

Through timely coverage, this relevant volume gives readers an appreciation for the unique political and socioeconomic landscape within which academic and entrepreneurial biotechnology laboratories operate. Coverage includes a focus on the financial, technological, and infrastructure-building activities underway (primarily in Asia) that are reminiscent of the infrastructure building in the semiconductor industry.

Because the biotechnology field crosses so many traditional boundaries, successful CEOs and other senior-level corporate executives in the industry need a guide to both business principles and the biology, physics, and information technologies related to their company’s products and services. The global market also demands successful executives be skilled in public relations and managing the press with due respect to social, political, and religious concerns surrounding biotechnology research.

Private and government-sponsored laboratories in Asia are scrambling to develop many of the core technologies that will drive biotechnology developments in the United States, European Union, Australia, and elsewhere. Biotech Industry: A Global, Economic, and Financing Overview offers valuable insight into where this major research is being conducted, where it’s being applied, and where money and intellectual capital are flowing.

Les mer

Produktdetaljer

ISBN
9780471465614
Publisert
2004-02-25
Utgiver
John Wiley & Sons Inc
Vekt
631 gr
Høyde
244 mm
Bredde
162 mm
Dybde
31 mm
Aldersnivå
P, 06
Språk
Product language
Engelsk
Format
Product format
Innbundet
Antall sider
384

Biografisk notat

Bryan Bergeron is the author of twelve books, including Essentials of Shared Services, Essentials of Knowledge Management, and Business Expectations: Are You Using Technology to its Fullest? (all published by Wiley). He also serves as editor in chief of e.MD and technical editor of Postgraduate Medicine, is on the editorial boards of Healthcare Informatics and Perspectives in Biology and Medicine, and is a columnist for WebMD. He teaches technology and business courses at Harvard Medical School and MIT.

Paul Chan is a columnist specializing in technology finance, value-based management, and private equity for Asia's leading business newspaper, Business Times, where he currently heads the new media unit. He has had a long and successful career as an equity strategist and management consultant, and he has advised a gamut of global institutional investors. He also has directed equity research at some of Asia's largest brokerage houses.